BioPharmX Corporation (BPMX) financial statements (2021 and earlier)

Company profile

Business Address 110 ALLEN ROAD, SUITE 401
BASKING RIDGE, NJ 07920
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments10138742
Cash and cash equivalents10138742
Receivables  00000
Inventory, net of allowances, customer advances and progress billings   0000
Inventory   0000
Other current assets0      
Other undisclosed current assets 000000
Total current assets:11138743
Noncurrent Assets
Operating lease, right-of-use asset1 
Property, plant and equipment 000000
Intangible assets, net (including goodwill)     00
Intangible assets, net (excluding goodwill)     00
Deposits noncurrent assets0      
Restricted cash and investments     00
Other noncurrent assets 00 000
Other undisclosed noncurrent assets 1     
Total noncurrent assets:1100000
TOTAL ASSETS:12248753
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:1223421
Accounts payable0111320
Accrued liabilities1112100
Employee-related liabilities     00
Other undisclosed accounts payable and accrued liabilities(0)      
Debt 0     
Due to related parties     00
Deferred revenue and credits  00
Other undisclosed current liabilities1    00
Total current liabilities:1223431
Noncurrent Liabilities
Long-term debt and lease obligation1      
Long-term debt, excluding current maturities0      
Operating lease, liability1 
Liabilities, other than long-term debt00 00  
Deferred income tax liabilities0 
Other liabilities00     
Derivative instruments and hedges, liabilities   00  
Other undisclosed noncurrent liabilities 10    
Total noncurrent liabilities:11000  
Total liabilities:2223431
Stockholders' equity
Stockholders' equity attributable to parent8(0)1532(5)
Preferred stock    2  
Common stock0000000
Additional paid in capital2688806646284
Accumulated deficit(18)(88)(79)(61)(45)(26)(9)
Other undisclosed stockholders' equity2     7
Total stockholders' equity:10(0)15322
TOTAL LIABILITIES AND EQUITY:12248753

Income statement (P&L) ($ in millions)

12/31/2020
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
12/31/2014
Revenues0 0000 
Revenue, net000 
Sublease income0 
Cost of revenue
(Cost of Goods and Services Sold)
  (0)(0)(1)(0) 
Gross profit:0 (0)(0)(0)(0) 
Operating expenses(21)(10)(16)(17)(18)(15)(8)
Operating loss:(20)(10)(17)(17)(18)(15)(8)
Nonoperating income (expense)5(0)(1)(0)(0)(0)0
Debt instrument, convertible, beneficial conversion feature      0
Other nonoperating income (expense)(4)(0)(1)(0)(0)(0)0
Interest and debt expense    (0) (0)
Loss from continuing operations before equity method investments, income taxes:(15)(10)(17)(17)(19)(16)(8)
Other undisclosed income from continuing operations before income taxes 0000  
Loss from continuing operations before income taxes:(15)(10)(17)(17)(18)(16)(8)
Income tax expense(0)(0)(0)(0)(0)(0) 
Net loss:(15)(10)(17)(17)(18)(16)(8)
Other undisclosed net loss attributable to parent      (0)
Net loss attributable to parent:(15)(10)(17)(17)(18)(16)(8)
Preferred stock dividends and other adjustments(0)    (0)(0)
Other undisclosed net loss available to common stockholders, basic(0)   (0)  
Net loss available to common stockholders, diluted:(15)(10)(17)(17)(19)(16)(8)

Comprehensive Income ($ in millions)

12/31/2020
1/31/2020
1/31/2019
1/31/2018
1/31/2017
1/31/2016
12/31/2014
Net loss:(15)(10)(17)(17)(18)(16)(8)
Comprehensive loss, net of tax, attributable to parent:(15)(10)(17)(17)(18)(16)(8)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: